Sign Up to like & get
recommendations!
0
Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30813
Abstract: Hepatocellular carcinoma (HCC) incidence in the U.S. is increasing in specific subgroups of patients such as white men with hepatitis C and Hispanics with non-alcoholic fatty liver disease.(1) HCC is the only cancer type with…
read more here.
Keywords:
hepatocellular carcinoma;
dose duration;
carcinoma;
use reduce ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of the Royal Society Interface"
DOI: 10.1098/rsif.2019.0815
Abstract: Human mesenchymal stromal cells (MSCs) are a leading cell therapy candidate for the treatment of immune and inflammatory diseases due to their potent regulation of immune cells. MSC expression of indoleamine-2,3-dioxygenase (IDO) upon interferon γ…
read more here.
Keywords:
pre licensing;
mesenchymal stromal;
dose duration;
expression ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.17241
Abstract: Keith Gomez, Mike Laffan and Charlotte Bradbury Haemophilia Centre and Thrombosis Unit, Royal Free Hospital London NHS Foundation Trust, London, Department of Immunity and Inflammation, Centre for Haematology, Faculty of Medicine, Imperial College London, London,…
read more here.
Keywords:
dose duration;
duration anticoagulants;
prevention venous;
anticoagulants prevention ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Current drug discovery technologies"
DOI: 10.2174/1570163816666190226100812
Abstract: OBJECTIVE Hypertension is an important risk factor that causes many deaths in the world every year. Researchers continue to undertake studies to find an effective drug for reducing blood pressure. One of the phytochemical that…
read more here.
Keywords:
resveratrol;
dose duration;
systematic review;
blood pressure ... See more keywords